Showing results (1751-1760 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like EffectFabio Del Bello, Eleonora Diamanti, Mario Giannella, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide designFabián Villalta-Romero, Anna Gortat, Andrés E Herrera, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activitySunny Manohar, U Chinna Rajesh, Shabana I Khan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer TherapeuticsMustapha Haddach, Michael K Schwaebe, Jerome Michaux, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic EffectsCurt A Dvorak, Changlu Liu, Jonathan Shelton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase InhibitorsJunwon Kim, Doohyun Lee, Changmin Park, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA InhibitorsTao Wang, Michelle L Lamb, Michael H Block, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylasesChristian A Olsen, Ana Montero, Luke J Leman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of DS-8108b, a Novel Orally Bioavailable Renin InhibitorYuji Nakamura, Teppei Fujimoto, Yasuyuki Ogawa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fluorescent Human EP3 Receptor AntagonistsMiriam Tomasch, J Stephan Schwed, Karina Kuczka, et al.
Pageof 438